Despite the efficacy and widespread use of methylphenidate (MPH) as a treatment modality for attention deficit hyperactivity disorder, clinical and preclinical findings indicate that it has abuse potential. Environmental enrichment reduces susceptibility to cocaine and amphetamine self-administration and decreases impulsive behavior, but its effects on MPH self-administration are unknown. The present experiments sought to determine the influence of environmental enrichment on MPH self-administration. Male rats were raised in an enriched condition (EC) or isolated condition (IC). They were trained to self-administer MPH (0.3 mg/kg/infusion) and then exposed to varying doses of MPH on either a fixed-ratio (experiment 1) or a progressive-ratio (experiment 2) schedule of reinforcement. EC rats earned significantly fewer infusions of MPH at low doses (0.03 and 0.056 mg/kg/infusion) compared with IC rats under both schedules; however, no differences were observed at high unit doses (0.1-1.0 mg/kg/infusion). During saline substitution at the end of MPH self-administration, EC rats also responded less for saline compared with IC rats, indicative of more rapid extinction. As with other stimulant drugs with different mechanisms of action, environmental enrichment during development protects against self-administration of MPH at low unit doses but not at high unit doses.
Introduction
Methylphenidate (MPH) is a widely prescribed psychomotor stimulant for the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. There has been a considerable increase in ADHD diagnoses over the past decade accompanied by an increase in MPH prescription rates (Hoagwood et al., 2000) . Currently, MPH comprises B56% of ADHD prescriptions (Setlik et al., 2009) . Although MPH is effective for managing the symptoms of ADHD, its potential for abuse is high, especially among adolescents and young adults (see Kollins et al., 2001; Brown et al., 2005 for review) . For example, misuse of MPH has been reported by students in elementary school, middle school, high school, and college and as many as 16% of elementary school children have been asked to sell, trade, or give away their prescription MPH (Musser et al., 1998; McCabe et al., 2004; Teter et al., 2006) .
There is clear evidence that abuse of MPH stems from its reinforcing properties. Children diagnosed with ADHD will choose capsules containing MPH more often than placebo or no capsules (MacDonald and Kollins, 2000) . Also, stimulant-abusing and nonabusing adults will respond for MPH capsules at rates similar to those responding for amphetamine Stoops et al., 2004) . MPH also functions as a reinforcer in nonhuman laboratory animals. For example, rats, dogs, and nonhuman primates will self-administer MPH intravenously in a dose-dependent manner at rates similar to cocaine and amphetamine (Griffiths et al., 1975; Johanson and Schuster, 1975; Risner and Jones, 1976; Bergman et al., 1989; Botly et al., 2008; Marusich et al., 2010 Marusich et al., , 2011a . One criterion for drug reinforcement is that subjects respond specifically because of the contingency to earn drugs (Meisch, 1987) , and previous work from our laboratory has demonstrated that MPH self-administration meets this criterion (Marusich et al., 2010) . Also, rats given extended access to MPH selfadministration at a low unit dose (0.1 mg/kg/infusion) will show an escalation of intake across sessions (Marusich et al., 2010) . This dysfunctional pattern of drug intake (i.e. an escalation in the amount of drug taken over time) is a hallmark sign of substance use disorders (Koob and Kreek, 2007) . Moreover, drug discrimination studies across species indicate that the discriminative stimulus effects of amphetamine, methamphetamine, and cocaine generalize to MPH (Rush et al., 1998; Kollins et al., 2001; Sevak et al., 2009) .
Although genetics and individual characteristics (e.g. age, sex, impulsivity) can influence susceptibility to drug abuse, the physical and social environment can also mediate the reinforcing effects of drugs. The environmental enrichment paradigm has revealed a host of effects on drug-seeking and drug-taking behaviors in rats. With this experimental design, rats are housed for several weeks either in an enriched condition (EC) with novel objects and social cohorts or in an isolated condition (IC) without novel objects or social cohorts Bardo, 2009, Simpson and Kelly, 2011) .
Environmental enrichment appears to have a protective effect against stimulant abuse. EC rats self-administer less cocaine or amphetamine on fixed-ratio (FR) schedules compared with IC rats (Howes et al., 2000; Bardo et al., 2001; Green et al., 2002; Gipson et al., 2011) . However, these differences in self-administration are only observed at low unit doses and diminish at higher doses. Similar results have been found using progressive-ratio (PR) schedules. PR schedules measure the reinforcing effect of a drug by systematically increasing the response requirement until the animal no longer responds (Richardson and Roberts, 1996; Stafford et al., 1998) . IC rats expend more effort compared with EC rats to receive a single infusion of a low unit dose of cocaine or amphetamine (Bardo et al., 2001; Green et al., 2002; Smith et al., 2009 ). In addition, the presence of social cohorts and/or novel objects can affect escalation, extinction, and reinstatement of drug-seeking behavior (Chauvet et al., 2009; Gipson et al., 2011; Thiel et al., 2011) .
Environmental enrichment may influence drug-taking behavior because of its ability to decrease impulsivity. Clinical and preclinical studies have found that subjects with greater inhibitory control are less prone to selfadminister and abuse drugs (see Carroll, 2008, Carroll et al., 2009 for reviews). EC rats show greater response inhibition and less premature anticipatory responding compared with rats raised in isolation (Ough et al., 1972; Wood et al., 2006) . also showed that acute MPH or amphetamine, both widely prescribed ADHD medications, significantly reduced impulsive choice in IC rats but not in EC rats. However, it remains to be determined whether enrichmentinduced differences occur with MPH self-administration (Bardo et al., 2001; Green et al., 2002) . In contrast to amphetamine, MPH does not reverse the dopamine transporter (DAT) or serotonin transporter; rather, it blocks uptake of both dopamine (DA) and norepinephrine (Han and Gu, 2006; Wilens, 2008) . However, given their common abuse liability, it was hypothesized that environmental enrichment would reduce MPH selfadministration using either FR or PR schedules of reinforcement.
Methods

Subjects and rearing conditions
Subjects were male Sprague-Dawley rats that were 21 days old upon arrival (Harlan Industries, Indianapolis, Indiana, USA). Rats were assigned randomly to an EC or IC group. Beginning at 21 days of age, rats were housed in their respective conditions. EC rats were housed in groups of 6-12 rats in large stainless steel wire cages (60 Â 120 Â 45 cm) with solid steel floors and pine bedding. They were exposed to 14 hard, nonchewable plastic objects placed randomly in the cage. Each day, seven of the 14 objects were replaced with new plastic objects. The remaining seven objects were also rearranged to maximize novelty. Plastic objects included tubes, balls, and toys. EC rats were handled daily. IC rats were housed individually in wire mesh hanging cages (17 Â 24 Â 20 cm) with solid metal sides and back walls. These rats were not handled until the experimental protocol began and were not given exposure to plastic objects. Rats were maintained in the same home environment throughout the duration of the experiment. All rats were experimentally and drug naive before the beginning of the experiment. Rats were housed in a colony on a 12:12 h light/dark cycle (lights on at 07:00 h). They had free access to water and food in the home cage. Experimental protocols were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Kentucky and followed the principles of laboratory animal care (National Research Council, 1996) .
Apparatus
Experimental sessions were conducted in standard rat operant conditioning chambers (28 Â 24 Â 25 cm; ENV-001; MED Associates, St Albans, Vermont, USA) housed inside sound-attenuating chambers (ENV-018M; MED Associates). Retractable levers (4.5 cm) were located on the front wall 6 cm above the floor on each side of a recessed food receptacle. White stimulus lights (28 V; 3 cm in diameter) were located 3 cm above each lever. Side walls were made of plexiglass, the front and back walls were aluminum, and floors were made of metal rods. A fan located inside the sound-attenuating chamber produced noise to mask extraneous sounds. Experimental events were arranged and recorded by MED-PC software (Med Associates) on a computer in the experimental room.
Surgery
Before any experimental manipulations, rats were surgically implanted with a chronic indwelling jugular catheter (0.2 mm in diameter) at approximately postnatal day 55. Rats were anesthetized with ketamine and diazepam (100 and 5 mg/kg, respectively, intraperitoneally). One end of the catheter was inserted into the jugular vein, and the other end was attached to a metal cannula that exited subcutaneously. The cannula was secured in a head mount adhered to the skull with dental acrylic and metal jeweler's screws. Rats were given 1 week to recover before self-administration began. Catheter patency was maintained by 0.2 ml infusions of a mixture containing 20 ml saline, 0.6 ml heparin (1000 USP units/ml), and 0.2 ml gentamicin (10 mg/ml) administered daily after experimental sessions. Before daily experimental sessions, cannulae were attached to tubing within a flexible, spring-covered leash (PHM-120; MED Associates) that was connected to a swivel (PHM-115; MED Associates) outside the operant conditioning chamber. This tubing exited the operant chamber and was connected to an infusion pump (PHM-100; MED Associates) located adjacent to the sound-attenuating chamber.
Experiment 1 Acquisition of methylphenidate self-administration
Following surgery, rats were trained to press a lever for intravenous MPH (0.3 mg/kg/infusion, 0.1 ml/infusion, 5.9 s/infusion) through the method of autoshaping (Carroll and Lac, 1993) . Rats were exposed to 1 h autoshaping sessions for seven consecutive daily sessions in which the active (drug) lever was extended into the chamber on a random schedule of 60 s. Following 15 s of lever extension or a lever press, the lever retracted and an infusion of MPH was delivered. The infusion was paired with a 20-s time-out signaled by the illumination of both stimulus lights during which lever pressing had no programmed consequence. The inactive lever (no drug) was present continuously, except during time-outs. The side of the operant conditioning chamber corresponding to the active lever was counterbalanced across rats. Rats were delivered 10 infusions of MPH during the first 15 min of the session. Rats then remained in the chamber for an additional 45 min with only the inactive lever present (no drug infusions). Autoshaping sessions were paired with a subsequent daily session in which MPH (0.3 mg/kg/infusion) was available on an FR 1 schedule for 60 min, with the active lever being the same one paired with drug during the autoshaping session. The daily autoshaping and FR 1 sessions were separated by B60 min. Following seven consecutive days of paired autoshaping and FR 1 sessions, autoshaping sessions were terminated, but FR sessions continued; rats were given access to MPH (0.3 mg/kg/infusion) on an FR 1 schedule for 3 consecutive days, followed by 3 days on FR 2, 3 days on FR 3, 3 days on FR 4, and 7 days on FR 5. All FR sessions were 60 min in duration.
During the next phase of the experiment, rats were given access to different doses of MPH for self-administration on an FR 5 schedule of reinforcement. Subjects were exposed to 0.03, 0.056, 0.1, 0.56, and 1.0 mg/kg/infusion MPH, with half the rats in each housing group exposed to these doses in ascending order and the other half exposed to these doses in descending order. Rats were given access to each dose for three consecutive sessions. Finally, all rats were tested on saline substitution for seven consecutive sessions.
Experiment 2 Acquisition of methylphenidate self-administration
Autoshaping and initial FR training were similar to that described in experiment 1.
Methylphenidate dose-effect determination using a progressive-ratio schedule Following acquisition, rats were given access to different doses of MPH for self-administration on a PR schedule of reinforcement. The response requirement required to earn an infusion increased exponentially (1, 2, 4, 6, 9, 12, 15, 20, 25, 32, 40, 50, 62, 77, 95, 118, 145, 178, 219, 268, etc.; Richardson and Roberts, 1996) following each infusion. Each 0.1 ml infusion was followed by a 20-s timeout signaled by the illumination of both stimulus lights. Sessions lasted for 5 h and were ended prematurely if there was no responding on the active lever for at least 1 h. At the start of this phase, subjects were given access to 0.3 mg/kg/infusion on the PR schedule for a minimum of three consecutive days. Upon reaching stability (i.e. <20% variability in the number of infusions earned across three consecutive sessions) with the training dose, rats were exposed to 0.03, 0.1, 0.3, and 1.0 mg/kg/infusion MPH in either ascending or descending order. Rats were given access to each dose for three consecutive sessions and the order in which they proceeded through the doses was counterbalanced for each housing condition. Finally, all rats were tested on saline substitution for seven consecutive sessions. Doses were selected based on those from experiment 1.
Drug
MPH HCl (Mallinckrodt, St Louis, Missouri, USA) was prepared in sterile 0.9% NaCl (saline).
Statistical analyses
The phases were defined as acquisition and dose-effect determination (including saline). Acquisition was further divided into autoshaping and incremental FR phases. To determine acquisition of MPH self-administration, the number of infusions and inactive lever presses were analyzed separately with mixed factor analyses of variance (ANOVAs). Schedule and session served as withinsubject factors and environmental condition served as a between-subject factor. Data for statistical and graphical analysis included each of the seven FR 1 sessions during autoshaping and the final three sessions on each FR schedule (FR 1-FR 5) during the FR phase.
For the dose-effect determination phase, the number of infusions earned and inactive lever presses were analyzed with a mixed factor ANOVA, with dose and session as within-subject factors and environmental condition and dose order (ascending or descending) as between-subject factors. Data for statistical and graphical analysis included the final two sessions of exposure to each dose and the final three sessions of exposure to saline. All tests were considered significant at P value less than 0.05. Significant interactions were subject to post-hoc Bonferronicorrected paired sample t-tests that were considered significant at P value less than 0.007 (with seven comparisons) in experiment 1 and at P less than 0.01 (with five comparisons) in experiment 2. If a catheter malfunctioned, the rat was removed from the experiment, and all data from that rat were excluded from that phase. Figure 1 depicts the number of infusions earned during acquisition of MPH self-administration (EC, n = 9; IC, n = 9). During the autoshaping phase, a two-way ANOVA (2 Â 7; environment Â session) revealed a significant main effect of session [F(6, 96) = 4.38, P < 0.001] but no significant main effect of environment or interaction. During the incremental FR phase, a three-way ANOVA (2 Â 5 Â 3; environment Â schedule Â session) revealed a significant main effect of schedule [F(4, 64) = 7.68, P < 0.001], in which the number of infusions declined with increasing FR values for both EC and IC rats. There were no significant differences in responding on the inactive lever during any phase of acquisition (results not shown). Figure 2 depicts the number of infusions earned for each unit dose of MPH and saline under an FR 5 schedule (EC, n = 9; IC, n = 8). A four-way ANOVA (2 Â 7 Â 2 Â 2; environment Â dose Â dose order Â session) revealed significant main effects of environment [F(1, 13) = 6.32, P < 0.05] and dose [F(6, 78) = 24.45, P < 0.001] and a significant environment Â dose interaction [F(6, 78) = 4.93, P < 0.001]. A Bonferroni-corrected pairwise comparison indicated that there was a significant difference between EC and IC rats in the number of infusions earned only at the 0.056 mg/kg/infusion dose and saline. There was a significant main effect of dose on responding on the inactive lever [F(6, 78) = 2.81, P < 0.05], in which greater responding on the inactive lever occurred at lower doses compared with higher doses (results not shown). There was no significant effect of dose order on either the number of infusions earned or inactive lever presses. Figure 3 illustrates the number of infusions earned during acquisition of MPH self-administration (EC, n = 6; IC, n = 7). During the autoshaping phase, a two-way ANOVA (2 Â 7; environment Â session) revealed significant main effects of environment [F(1, 11) = 4.70, P < 0.05] and session [F(6, 66) = 2.47, P < 0.05], indicating that EC rats earned fewer infusions compared with IC rats and that both groups earned more infusions as sessions progressed. During the incremental FR phase, a three-way ANOVA (2 Â 5 Â 3; environment Â schedule Â session) revealed a significant main effect of schedule [F(4, 44) = 2.75, P < 0.05], with the number of infusions earned declining as the FR value increased. There were no significant differences in responding on the inactive lever during either phase of acquisition (results not shown).
Results
Experiment 1 Acquisition
Dose-effect determination
Experiment 2 Acquisition
Dose-effect determination
The dose-effect determination for MPH self-administration under a PR schedule is shown in Fig. 4 (EC, n = 6; IC, n = 7). A four-way ANOVA (2 Â 5 Â 2 Â 2; 
Discussion
MPH is a reinforcer in rats (Botly et al., 2008; Marusich et al., 2010 Marusich et al., , 2011a and this is the first study, to our knowledge, to examine the influence of environmental enrichment on MPH self-administration. Rats were raised in enriched or isolated conditions and trained to self-administer MPH (0.3 mg/kg/infusion). Dose-dependent changes in the reinforcing effects of MPH were then determined using FR and PR schedules. Our results indicate that providing enrichment during development protects against self-administration of MPH at low unit doses, but these protective effects do not generalize to higher doses.
The literature supports that environmental enrichment, in the form of social cohorts and/or novel objects, has a number of protective effects across the different stages of drug abuse, including acquisition, maintenance, escalation, extinction/withdrawal, and reinstatement (Smith et al., 1997; Bardo et al., 2001; Stairs et al., 2006; Chauvet et al., 2009; Gipson et al., 2011; Ranaldi et al., 2011; Thiel et al., 2011) . Specifically, other studies have shown that rats raised in an enriched environment self-administer less amphetamine and cocaine at low unit doses compared with rats raised in isolation. For example, EC rats earned fewer infusions of a low dose of amphetamine under both FR and PR schedules compared with IC rats (Smith et al., 1997; Bardo et al., 2001; Green et al., 2002) . Similarly, rats raised with social cohorts respond less compared with rats raised in isolation for a low dose of cocaine under FR and PR schedules (Boyle et al., 1991; Smith et al., 1997 Smith et al., , 2009 Howes et al., 2000) . The MPH dose-effect functions under both the FR and PR schedules in this study mirror the dose-effect functions described in these previous experiments. That is, EC rats earned fewer infusions and had lower breakpoints compared with IC rats at low doses of MPH (0.03 and 0.056 mg/kg/infusion), suggesting that environmental enrichment reduces sensitivity to the reinforcing effect of MPH. However, because the protective effect exists only at low doses, the translational significance of these findings may be limited. In contrast to the protective effect seen during doseeffect determination, enrichment did not have a protective effect against the acquisition of MPH self-administration in experiment 1. However, in experiment 2, EC rats earned fewer infusions of MPH compared with IC rats during the initial autoshaping phase; this effect diminished across sessions and was not observed during the FR phase. These findings contrast with previous work showing that EC rats acquire cocaine and amphetamine self-administration more slowly compared with IC rats (Howes et al., 2000; Green et al., 2002) . However, in these latter studies, differential rates of acquisition occurred only with a low unit dose of cocaine or amphetamine. Whether EC or IC rats differ in the acquisition of MPH at doses other than the training dose used here (0.3 mg/kg/infusion) remains to be determined.
Several explanations may account for environmentinduced differences in MPH self-administration. First, environmental enrichment may alter neuronal function. EC rats have reduced DAT functioning in the medial prefrontal cortex, as indicated by a decrease in maximum velocity of [ 3 DA] uptake, compared with IC rats (Zhu et al., 2004; Wooters et al., 2011) . EC rats also have a decrease in DAT cell surface expression in this region (Zhu et al., 2005) . As a link within the mesocorticolimbic DA neurocircuitry, the mPFC is involved in the rewarding effects of drugs (Tzschentke, 2000) . As the reinforcing effect of MPH is likely due to DAT inhibition (Leonard et al., 2004; Wilens, 2008) , perhaps the enrichmentinduced decrease in DAT function in mPFC may attenuate the ability of MPH to serve as a reinforcer in EC rats.
An alternative explanation for the environment-induced differences in MPH self-administration may involve differences in impulsivity. Impulsivity has largely been considered a predictor of drug abuse susceptibility (Perry and Carroll, 2008; Carroll et al., 2009) . EC rats are less impulsive than IC rats on various tasks (Ough et al., 1972; Wood et al., 2006; ; therefore, EC rats may self-administer less MPH because of less impulsive behavior. Consistent with this hypothesis, rats with DA depletions in mPFC show enhanced impulsivity compared with nondepleted controls (Sokolowski and Salamone, 1994) . The increased DAT functioning of IC rats in the mPFC compared with EC rats (Zhu et al., 2004 (Zhu et al., , 2005 , and presumably reduced levels of extracellular DA in this region, may explain their impulsivity and propensity to self-administer. On the contrary, Marusich et al. (2011b) did not find significant relationships between impulsivity (using the delay-discounting and cued go/no-go tasks) and DA uptake or DAT affinity in mPFC of standardhoused rats.
Regardless of the neural mechanisms, a behavioral explanation for the environment-induced difference in MPH self-administration at low unit doses may involve differences in the rate of extinction or the reinstatement threshold. Stairs and Bardo (2009) suggest that total drug intake must surmount some minimum threshold to engender responding at the beginning of a session. If the unit dose of a drug is too low, responding may extinguish. However, several low-dose infusions in rapid succession may surpass the threshold and reinstate responding. Thus, diminished responding by EC rats at low unit doses may be a result of an increased rate of extinction within a session or because of an increased reinstatement threshold. For example, IC rats reinstate responding after a period of extinction following a low-dose priming injection of amphetamine, whereas EC rats require a highdose priming injection for reinstatement (Stairs et al., 2006) . Although the current experiment did not examine reinstatement of MPH-seeking specifically, differences in responding at the 0.03 and 0.056 mg/kg/infusion doses support this explanation.
In addition to MPH self-administration, EC rats responded less than IC rats when saline was substituted for MPH at the end of the experiment. This result accords with several other reports that found that EC rats emit fewer responses compared with IC rats under extinction conditions, indicative of enhanced extinction within a session (Gluck and Pearce, 1977; Green et al., 2002; Stairs et al., 2006; Smith et al., 2009) . Enhanced extinction may be reflective of improved learning by EC rats, as enrichment induces a number of neuroanatomical changes associated with enhanced learning (Rosenzweig and Bennett, 1996; Diamond, 2001; Kolb et al., 2003) . Alternatively, during saline substitution, EC rats may be less sensitive to either the secondary reinforcing effects of the cue light associated with MPH or the incentive motivation provided by the drug-associated lever (Robinson and Berridge, 2008; Beckmann and Bardo, 2012) , or may be less inclined to respond for the novelty provided by the cue lights signaling the time-out (Cain et al., 2006) . In any case, as EC and IC rats did not differ in responding on the inactive lever, it is likely that environment-induced differences reflect specific behaviors that are goal-directed rather than nonspecific differences in general activity.
Conclusion
MPH is an effective treatment method for reducing the symptoms of ADHD (e.g. impulsivity) in human and nonhuman subjects (Brown et al., 2005; , and prescription stimulants may protect against the development of substance use disorders (Biederman et al., 1999; Wilens et al., 2003 ; but see Mannuzza et al., 2003; Herin et al., 2010) . Nevertheless, much evidence indicates abuse potential. For example, animals used to model ADHD (e.g. IC rats or spontaneously hypertensive rats) find MPH to be rewarding and will self-administer the drug (Dela Peña et al., 2011; Marusich et al., 2011c) . Also, college students with hyperactive symptoms and high scores on measures of sensation-seeking are more likely to report misuse of their prescription stimulant Enrichment and MPH self-administration Alvers et al. 655
